SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 37 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -20.0% | 18,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | 0.0% | 18,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | -44.4% | 18,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | -18.2% | 18,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $11,000 | -15.4% | 18,500 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $13,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 331,543 | $90,000 | 0.01% |
| Sterneck Capital Management, LLC | 25,000 | $7,000 | 0.00% |
| Landmark Financial Advisors, LLC | 24,200 | $7,000 | 0.00% |
| Jacobi Capital Management LLC | 18,500 | $5,000 | 0.00% |
| MSD Partners, L.P. | 349,290 | $96,000 | 0.00% |
| Focused Wealth Management, Inc | 500 | $0 | 0.00% |
| UBS Group AG | 97,378 | $26,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 74,300 | $20,000 | 0.00% |
| IFP Advisors, Inc | 13,825 | $5,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $0 | 0.00% |